Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|December 21, 2013
A system for accurate and automated injection of hyperpolarized substrate with minimal dead time and scalable volumes over a large rangeSteven Reynolds, Adriana Bucur, Michael Port, et al.
Medical Engineering & Physics|October 12, 2010
Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to vascular targeting agentsSimon Akerman, Constantino Carlos Reyes-Aldasoro, Matthew Fisher, et al.
NMR in Biomedicine|March 1, 2002
Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRIRoss J Maxwell, John Wilson, Vivien E Prise, et al.
Magnetic Resonance in Medicine|February 14, 2017
Direct arterial injection of hyperpolarized <sup>13</sup> C-labeled substrates into rat tumors for rapid MR detection of metabolism with minimal substrate dilutionSteven Reynolds, Stephen Metcalf, Edward J Cochrane, et al.
NMR in Biomedicine|November 29, 2021
Kinetic modelling of dissolution dynamic nuclear polarisation <sup>13</sup> C magnetic resonance spectroscopy data for analysis of pyruvate delivery and fate in tumoursSteven Reynolds, Samira M Kazan, Adriana Anton, et al.
The Lancet. Oncology|February 3, 2007
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I studyQuan-Sing Ng, Vicky Goh, Jessica Milner, et al.
Microcirculation (New York, N.Y. : 1994)|October 24, 2007
Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivoConstantino Carlos Reyes-Aldasoro, Ian Wilson, Vivien E Prise, et al.
International Journal of Oncology|January 5, 2007
Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-downKatharine J Lankester, Ross J Maxwell, R Barbara Pedley, et al.
Advanced Drug Delivery Reviews|November 3, 2004
Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopyGillian M Tozer, Simon M Ameer-Beg, Jennifer Baker, et al.
The Journal of Clinical Investigation|April 15, 2011
TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in miceAbigail F Welford, Daniela Biziato, Seth B Coffelt, et al.
Pageof 7